Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Golden Cariboo (CSE:GCC) (OTC:GCCFF) Expands Gold Footprint in BC (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Price History
|
Ratios
|
Insiders
Bullboard - Stock Discussion Forum
Ocean Biomedical Inc (EM)
OCEA
Healthcare
Biotechnology
Ocean Biomedical, Inc., a biopharmaceutical company, focuses on discovering and developing therapeutic products in oncology, fibrosis, and infectious diseases in the United States. The company’s oncology product candidates include OCX-253 anti-Chi3l1 Single-target mAb and OCX-410 anti-Chi3l1/PD-1 Bi-specific antibody for the treatment of non-small cell lung cancer; and OCX-909 anti-Chi3l1/CTLA...
-4 Bi-specific antibody to treat glioblastoma multiforme. Its fibrosis product candidates consist of OCF-203 anti-Chit1 small molecule for the treatment of idiopathic pulmonary fibrosis (IPF) and hermansky-pudlak syndrome (HPS). The company’s infectious diseases product candidates for malaria include the ODA-570 vaccine for the prevention of P. falciparum infection; ODA-611 anti-PfGARP mAb for the treatment of Symptomatic P. falciparum infection; and ODA-579 anti-PfGARP small molecule for the treatment of Symptomatic P. falciparum infection. It has license agreement with Elkurt, Inc. for FRG An...
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Bullboard (EXPM:OCEA)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
Next
(187)
•••
coolfooldumbguy
X
Post by
coolfooldumbguy
on Feb 11, 2025 1:10pm
This stock is for swing trading only.
It was at the basement price per share and it is starting to climb up from the low prices per share.
(1)
•••
Prabhjitk
X
Post by
Prabhjitk
on Jun 12, 2024 3:51pm
Positive News from Joint Venture Partner! Good news for OCEA
OCEA Update: Positive News from Joint Venture Partner! Good news for OCEA! Their joint venture partner, Virion Therapeutics, achieved promising initial results in a Phase 1 human trial for their
...more
(0)
•••
PressRelease
X
Post by
PressRelease
on Jul 11, 2023 8:01am
New Press Release - Ocean Biomedical's (NASDAQ: OCEA) mRNA-based Vaccine Candidate Generates Over 90% Killing of Malaria Parasites in Non-human Primates, Demonstrating Broad Potential for Ocean's Program to Address Global and Emerging U.S. Malaria Challenges
Multiple Patents have been received in the U.S. and Internationally for Novel Vaccine Candidate and “Whole New Class” of Malaria Therapeutics. Providence, RI, July 11, 2023 (GLOBE NEWSWIRE) -- Ocean Biomedical, Inc. (NASDAQ: OCEA), a biopharma company working to accelerate the development of...
read article.
(0)
•••
PressRelease
X
Post by
PressRelease
on Jun 27, 2023 8:01am
New Press Release - Ocean Biomedical, Inc. Joins the Russell 2000® Index
Ocean Biomedical’s Inclusion in the Russell 2000® Index and Russell 3000® Index Builds Momentum for Cutting Edge Therapeutic Programs Targeting Multiple Cancers, Fibrotic Diseases, and Malaria Providence, RI, June 27, 2023 (GLOBE NEWSWIRE) -- Ocean Biomedical, Inc. (NASDAQ: OCEA) announced...
read article.
(1034)
•••
Iseneschal
X
Post by
Iseneschal
on Jun 26, 2023 8:10am
OCEA.... NR this a.m
Ocean Biomedical, Inc. (NASDAQ: OCEA) Announces U.S. Patent Issued for Bispecific Cancer Immunotherapy Treatment With Demonstrated Killing of Tumor Cells in Lung Cancer, Brain Cancer
...more
(1034)
•••
Iseneschal
X
Post by
Iseneschal
on Jun 23, 2023 8:09am
OCEA....Here it goes...over $7 in PM trading
$7.34 Cheers !
(1034)
•••
Iseneschal
X
Post by
Iseneschal
on Jun 22, 2023 12:21pm
OCEA....Let gooooooo !
$17 holla ?
(1034)
•••
Iseneschal
X
Post by
Iseneschal
on Jun 22, 2023 12:08pm
OCEA....You know this is going higher....
especially after this a.m's retracement to sub $6....added a position just above $6 this a.m ; ) They announced a price target of over $17/sh yesterday...let see if they full of BS or not
...more
(1034)
•••
Iseneschal
X
Post by
Iseneschal
on Jun 21, 2023 9:57am
OCEA....scalp #1
In sub $7 ....out $7.60
(55)
•••
JasleenDhaka
X
Post by
JasleenDhaka
on May 04, 2023 5:44pm
Anti-Chi3L1 antibody shows promising results
@OceanBiomedical's Anti-Chi3L1 antibody shows promising results, suppressing glioblastoma tumor growth by 60%. A major milestone as they file an application for human clinical trials with the FDA.
...more
(0)
•••
PressRelease
X
Post by
PressRelease
on Apr 06, 2023 8:01am
New Press Release - Ocean Biomedical (NASDAQ: OCEA) Will Target Pulmonary Fibrosis Discoveries as Novel Treatments of Hermansky-Pudlak Syndrome
On Hermansky-Pudlak Syndrome (HPS) Awareness Day, Ocean Biomedical announces acommitment to developingviable treatment options for HPS-1 and HPS-4Providence, RI, April 06, 2023 (GLOBE NEWSWIRE) -- Ocean Biomedical, Inc. (NASDAQ: OCEA) announced today a strong commitment to targeting its...
read article.
(55)
•••
JasleenDhaka
X
Post by
JasleenDhaka
on Mar 22, 2023 3:38pm
New Analyst Report on Ocean Biomedical
Report Release: Ocean Biomedical provides a platform for #innovators to bring their discoveries to market. The pharmaceutical industry is ripe for potential mergers and
...more
(0)
•••
PressRelease
X
Post by
PressRelease
on Mar 21, 2023 8:01am
New Press Release - Ocean Biomedical (NASDAQ: OCEA) Details Novel Malaria Therapeutic Discoveries at the NIH Laboratory of Malaria Vaccinology and Immunology on PfGARP's Potential as a Highly Effective Vaccine Target and Therapeutic Candidate to Treat Malaria
Providence, RI, March 21, 2023 (GLOBE NEWSWIRE) -- Ocean Biomedical, Inc., a biopharma company working to accelerate the development and commercialization of scientifically compelling assets from research universities and medical centers, announced today that its Scientific Co-founder, Jonathan...
read article.
(0)
•••
PressRelease
X
Post by
PressRelease
on Mar 16, 2023 8:01am
New Press Release - Ocean Biomedical (NASDAQ: OCEA) Announces Initiation of Equity Analyst Coverage by Fundamental Research Corp. with a "Buy" Recommendation
Providence, RI, March 16, 2023 (GLOBE NEWSWIRE) -- Ocean Biomedical, Inc. (NASDAQ: OCEA), a next generation biopharma company, announces initiation of equity analyst coverage by Fundamental Research Corp. with a “Buy” recommendation. “We are pleased to see initiation of additional research...
read article.
(0)
•••
PressRelease
X
Post by
PressRelease
on Mar 14, 2023 8:01am
New Press Release - Ocean Biomedical (NASDAQ: OCEA) Announces Initiation of Equity Analyst Coverage by EF Hutton with a "Buy" Recommendation
Providence, RI, March 14, 2023 (GLOBE NEWSWIRE) -- Ocean Biomedical, Inc. (NASDAQ: OCEA), a next generation biopharma company, announces initiation of equity analyst coverage by EF Hutton with a “Buy” recommendation. “We are honored to see independent institutional research analyst coverage...
read article.
Prev
1
2
3
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{previousButtonTitle}}
{{nextButtonTitle}}
A daily snapshot of everything
from market open to close.
Featured News Links
New Gold Opportunities in the Cariboo Region (CSE:GCC) (OTC:GCCFF)
Podcasts